The very slow progress in the treatment of severe diseases has led to the adoption of a multidisciplinary approach to the targeted delivery and release of drugs, underpinned by nanoscience and...
http://www.azonano.com/article.aspx?ArticleID=1702 | 23 Aug 2006
It is not widely known but radiactive gold was used in the treatment of cancer many years ago. Now a number of research groups around the world are using the unique properties of gold to develop new...
http://www.azonano.com/article.aspx?ArticleID=2406 | 1 Oct 2009
Research UK scientists have for the first time developed a treatment that
transports 'tumour busting' genes selectively to cancer cells, according to
a study published online in...
http://www.azonano.com/news.aspx?newsID=10360 | 12 Mar 2009
A revolutionary cancer treatment using microscopic magnets to
enable 'armed' human cells to target tumours has been developed by
researchers funded by the Biotechnology and Biological...
http://www.azonano.com/news.aspx?newsID=6293 | 18 Apr 2008
The research efforts taking place within The Nanomedicine Lab are bridging the gap between fundamental nanomaterials engineering and pharmaceutical development towards the realisation of advanced...
http://www.azonano.com/article.aspx?ArticleID=2604 | 25 May 2010
They can emerge even years after the successful treatment of a lung-, breast-
or skin cancer tumour: Metastases suddenly begin to grown in the brain. These
are of course extremely dangerous...
http://www.azonano.com/news.aspx?newsID=15377 | 8 Jan 2010
The potential for nanoparticles in cancer drug delivery is infinite with novel new applications constantly being explored. This paper explores the types and structures of nanoparticles used in cancer...
http://www.azonano.com/article.aspx?ArticleID=1903 | 14 May 2007
Reviewed herein are the most recent developments in the area of drug delivery systems. Systems such as colloidal dug carriers, micelles, liposomes, dendrimers, liquid crystals, nanopoarticles,...
http://www.azonano.com/article.aspx?ArticleID=1538 | 25 Mar 2006